Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Kazia Therapeutics Announced An Agreement With QIMR Berghofer Medical Research Institute To Obtain An Exclusive License To Certain Intellectual Property Rights In Relation To Combination Therapies Consisting Of Pi3K Inhibitor Drugs, And One Or More Immunotherapy Or PARP Inhibitor Drugs

Author: Benzinga Newsdesk | September 12, 2024 07:37am

Posted In: KZIA